News And Announcements
AstraZeneca's Imfinzi clears latest FDA regulatory hurdle
AstraZeneca and its global biologics research and development arm MedImmune announced on Tuesday that the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), for the treatment of patients with locally advanced (Stage III) unresectable non-small cell lung cancer (NSCLC) whose disease has not progressed following platinum-based chemoradiation therapy.
Big four supermarkets relying on inflation for growth - Nielsen, Kantar find
Major supermarket groups Tesco, Sainsbury's, Asda and Morrisons continued to both grow sales and lose ground to discounters, with Aldi and Lidl contributing the entire grocery market's volume growth in recent weeks.
Moneysupermarket Q3 revenue rises as insurance business does well
Price comparison website Moneysupermarket. com reported a jump in revenue for the third quarter and said it was “on track for another record year”.
Smiths Group appoints John Shipsey as CFO
Smiths Group has appointed John Shipsey as chief financial officer designate with effect from Wednesday.
Bellway profit rises as demand remains strong
FTSE 250 housebuilder Bellway reported a jump in full-year profit and revenue on Tuesday as demand for new housing remained strong.
Pearson tweaks profits guidance as US market not as bad as feared
Pearson's underlying revenues fell 2% in the first nine months of the year, largely as expected, but the educational publisher improved its earnings guidance and promised a £300m share buyback.
Rio Tinto cuts full-year copper guidance
Rio Tinto cut its copper guidance for the year on Tuesday as it reported a drop in mined copper in the third quarter.